Obesity Featured Articles

  1. A Roadmap To Expedited Review Pathways 6/12/2025

    Accelerated development and manufacturing timelines provide developers with paths to move new therapies to market quickly while still maintaining a balance of risk/benefit assessment. 

  2. J&J Survey Of Oncologists Reveals Challenges With Awareness & Access 6/12/2025

    J&J President, U.S. Solid Tumor Biljana Naumovic discusses the company's Oncology Care Index, which revealed issues with oncology provider awareness of and access to clinical trials.

  3. Huntington's Disease Clinical Trials: Innovation, Challenges, And The Road Ahead 6/11/2025

    The Huntington’s disease (HD) landscape is undergoing rapid transformation driven by breakthroughs in gene-targeted therapies, small-molecule modulators, regenerative medicine, and digital innovation.

  4. How Strategic Resourcing Accelerates Biotech's Path From Preclinical To FIH 6/11/2025

    Explore how strategic resourcing, particularly through FSP models, empowers biotech sponsors to overcome common hurdles transitioning when from preclinical research to first-in-human (FIH) trials.

  5. Improving Recruitment Needs More Than Transactional Fixes To Earn Patient Trust 6/11/2025

    Driving patient recruitment and retention in clinical trials isn't always about scheduling, transportation, or even reimbursement. Often, and especially for marginalized communities, it begins with trust.

  6. EHR-To-EDC Success In A Complex Oncology, Adaptive Platform Trial 6/10/2025

    The I-SPY 2 Trial represents a groundbreaking approach in oncology, with a key component of the trial's success being the integration of EHR with EDC via OpenClinica's Unite platform.

  7. Insights From 250+ Regulatory Inspections 6/10/2025

    Elisabeth George, who has led more than 250 FDA inspections, shares practical advice for hosting audits — including preparation tips, team coordination, live documentation, and knowing exactly when to speak.

  8. U.S. Tariffs And Their Tenuous Impact On Clinical Trials 6/10/2025

    RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.

  9. 6 Tips To Ensure Revenue Integrity And Compliance In Clinical Operations 6/9/2025

    Discover the importance of Medicare Coverage Analysis (MCA) and the rules of National Coverage Determination (NCD) in establishing financial security and regulatory adherence in clinical operations.

  10. Optimizing Clinical Data: Reducing Redundancy For Efficiency 6/6/2025

    Enabling sites to focus solely on critical data facilitates faster data entry, reduces queries, and fosters better relationships between sponsors, CROs, and sites.